Home-Based Cancer Care Report

The Home-Based Cancer Care report views cancer care at home as a growing trend in the market. The report provides background on this area of the market as well as a look at some of the leading providers of home-based cancer care.

Get this free report

Sample
Pharmacy in LTC 2021 Report

Download sample pages from AMI’s Pharmacy in LTC 2021 report that remains a vital resource for those in the market needing business intelligence. The report provides background and identifies the trends of the long-term care and senior living markets, as well as pharmacy’s market position. The report also identifies and provides profiles for each company. 

Get sample (free) Buy the Full Report

Sample
Top 50 Employer Profiles Report 2021

View sample profile information from AMI’s extensive Employer Profiles Report that saves you hours of research and deliver that vital intelligence in a form you can conveniently digest and deploy in planning strategy to increase your product’s sales.

Get sample (free) Buy the Full Report

Sample
GPOs 2021 Annual Review

The GPOs 2021 Annual Review  130+ pages, offers comprehensive intelligence on the leading group purchasing organizations, grouping the market into National GPOs, Pharmacy/Oncology GPOs, Physician GPOs, and Long-Term Care GPOs. AMI’s report also provides background on the market.

Get sample (free) Buy the Full Report

Achieve measurable success in the increasingly complex and rapidly changing world of healthcare today. AMI’s experienced leadership team has developed free white papers to help businesses better understand the challenges while offering new strategies and alternative approaches to help drive measurable success.

Get Download

Now available:

White Paper: Understanding Prior Authorization Challenges and Opportunities


This Free White Paper Uncovers New Strategies to Help Identify Measurable Value, Effective Drug Utilization and Control Costs for Healthcare Stakeholders.

Find out what’s going on behind the curtain of prior authorization for the medical and pharmacy benefit in our free white paper “Prior Authorization in Today’s Healthcare Dynamic Marketplace.”

Learn More

White Paper: Bend the Curve

A New Era for the Management of Specialty Pharmaceuticals

Biologic, biotechnology-based, rare disease, or high-cost pharmaceuticals — collectively known as specialty drugs — can be covered under the pharmacy benefit, the medical benefit, or both depending on the benefit design plan sponsors require of the third-party administrator (including the pharmacy benefit manager – PBM; administrative service organization – ASO; or any administrator of a medical or pharmacy benefit).

Click here and download the white paper.

On average, up to 50% of specialty drugs today are covered under the medical benefit.

With the exception of a few key therapy areas, traditional tools used to manage specialty drugs under the medical benefit, such as prior authorizations and medical benefit carve-outs (i.e., “white-bagging”), have yielded limited value to plan sponsors.

This thought leadership analysis, with insights from recognized industry experts, will provide an overview of the challenges, a summary of the key issues plan sponsors must address and insights into best practices through an innovative new approach, Medical Benefit Drug Management (MBM).

Get Download